TALISMAN THERAPEUTICS LIMITED
Company number 08473331 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£641,237
Balance sheet as at 2025-04-30
Overview
- Company type
- Private Limited Company
- Incorporated
- 2013-04-04
- Employees
- 15 (2025 accounts · was 14 in 2024)
- Registered office
- Babraham Hall, Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT
- Postcode
- CB22 3AT
- Capital
- 116 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-04-30
- Next due by
- 2027-01-31
- Financial year end
- 30 April
Confirmation statement
- Last statement dated
- 2026-03-18
- Next due by
- 2027-04-01
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 3 current · 1 resigned
Contact details
- Website
- talismantherapeutics.uk
Talisman Therapeutics is committed to revolutionising the discovery of disease-modifying treatments for neurodegenerative diseases. We use cutting-edge stem cell technologies to answer the most difficult biological questions in target discovery and validation. Our team combines commercial rigour with innovative thinking and problem-solving.
Previous registered addresses 2
| Address | Changed on |
|---|---|
| C/O SLATER HEELIS LLP, 86 DEANSGATE, MANCHESTER, M3 2ER | 2015-12-04 |
| C/O WEIGHTMANS LLP, PALL MALL COURT 61-67 KING STREET, MANCHESTER, M2 4PD | 2014-10-16 |
Among its peers
Among the biggest employers
of 158 similar companies in CB, with 15 staff. Among the oldest 25% of its local peers.
Competitors Cambridge
This company ranks 62 among research and experimental development on biotechnology in Cambridge.
The class of 2013
32%
of the 312 companies in this sector incorporated in 2013 are still active today; 63% have since been dissolved.
A fact about the year, not a forecast for this company.